These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 24111638)
1. Analysis of FEV1 decline in relatively healthy heavy smokers: implications of expressing changes in FEV1 in relative terms. Thomsen LH; Dirksen A; Shaker SB; Skovgaard LT; Dahlbäck M; Pedersen JH COPD; 2014 Feb; 11(1):96-104. PubMed ID: 24111638 [TBL] [Abstract][Full Text] [Related]
2. Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease. Pope CA; Kanner RE Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1336-40. PubMed ID: 8503541 [TBL] [Abstract][Full Text] [Related]
3. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140 [TBL] [Abstract][Full Text] [Related]
4. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038 [TBL] [Abstract][Full Text] [Related]
5. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers. Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262 [TBL] [Abstract][Full Text] [Related]
6. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Mohamed Hoesein FAA; Zanen P; Boezen HM; Groen HJM; van Ginneken B; de Jong PA; Postma DS; Lammers JJ Chest; 2012 Dec; 142(6):1530-1538. PubMed ID: 22722231 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis. Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846 [TBL] [Abstract][Full Text] [Related]
8. Impact of cigarette smoking on decline in forced expiratory volume in 1s relative to severity of airflow obstruction in a Japanese general population: The Yamagata-Takahata study. Sato K; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Nemoto T; Sato M; Nakano H; Machida H; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Yamamoto T; Watanabe T; Konta T; Ueno Y; Kato T; Kayama T; Kubota I Respir Investig; 2018 Mar; 56(2):120-127. PubMed ID: 29548649 [TBL] [Abstract][Full Text] [Related]
9. Effects of the multiple risk factor intervention trial smoking cessation program on pulmonary function. A randomized controlled trial. Browner WS; Du Chene AG; Hulley SB West J Med; 1992 Nov; 157(5):534-8. PubMed ID: 1441495 [TBL] [Abstract][Full Text] [Related]
10. [Effects of smoking habits on pulmonary function. Cross-sectional and longitudinal studies in male subjects on medical check-up]. Omori H; Morimoto Y Nihon Kokyuki Gakkai Zasshi; 2004 Apr; 42(4):306-12. PubMed ID: 15114846 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal decline in lung function: a community-based cohort study in Korea. Leem AY; Park B; Kim YS; Chang J; Won S; Jung JY Sci Rep; 2019 Sep; 9(1):13614. PubMed ID: 31541126 [TBL] [Abstract][Full Text] [Related]
12. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Islam SS; Schottenfeld D Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576 [TBL] [Abstract][Full Text] [Related]
13. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Tashkin DP; Simmons MS; Sherrill DL; Coulson AH Am J Respir Crit Care Med; 1997 Jan; 155(1):141-8. PubMed ID: 9001303 [TBL] [Abstract][Full Text] [Related]
14. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996 [TBL] [Abstract][Full Text] [Related]
15. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Wise RA Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894 [TBL] [Abstract][Full Text] [Related]
16. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. Peat JK; Woolcock AJ; Cullen K Thorax; 1990 Jan; 45(1):32-7. PubMed ID: 2321175 [TBL] [Abstract][Full Text] [Related]
17. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672 [TBL] [Abstract][Full Text] [Related]
18. Association of occupational pesticide exposure with accelerated longitudinal decline in lung function. de Jong K; Boezen HM; Kromhout H; Vermeulen R; Postma DS; Vonk JM Am J Epidemiol; 2014 Jun; 179(11):1323-30. PubMed ID: 24780843 [TBL] [Abstract][Full Text] [Related]
19. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Vestbo J; Prescott E; Lange P Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597 [TBL] [Abstract][Full Text] [Related]
20. Rate of decline of lung function in subjects with asthma. Peat JK; Woolcock AJ; Cullen K Eur J Respir Dis; 1987 Mar; 70(3):171-9. PubMed ID: 3569449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]